Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UDCA versus placebo for dissolution of small cholesterol gallstones
2005-005919-24Phase 3Completed
- Sponsor
- Dr. Falk Pharma GmbH
- Start
- Apr 2006
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in cholelithiasis comparing Ursofalk with Placebo (2 arms). Primary endpoints: Complete dissolution of gallstones, Incidence of biliary colic and 2 more. Started Apr 2006; status: completed.
02
Drugs
ursodeoxycholic acid
03
Conditions
cholelithiasis
Beyond the preview
Go deeper on 2005-005919-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005919-24.